Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Mohammed Hassan


Mohammed Hassan

University of the Western Cape, South Africa

Biography

MOHAMMED HASSAN is currently a Masters of Sciencec (MSc) student in Biotechnology at the University of the Western Cape (UWC), South Africa. Prior to his MSc, he completed his Honours and his thesis focused on developing of gentyping system for pharmacogenomics profiling cholesterol lowering drugs In 2016, Hassan completed his biotechnology Bachelor of Science (cum laude) at Omdurman Islamic University, Sudan. Hassan is a recipient of the Golden Key International Award, 2017. Hassan's current researcher within the Bioinformatics research group (BRG) in  the Biotechnology department focuses on genetic biomarkers using computational methods. Genetics biomarkers in breast cancer treatment is the key to fight the multidrug resistance in chemotherapy treatment. ABC transporter genes as genetic biomarkers are crucial receptors for an effective management of chemotherapy resistance of breast cancer patients being treated with tamoxifen. Therefore, there is a need to understand the genetic diversity of ABC transporters in different populations so that we can give Tamoxifen to the right population group. The chairperson of the group is Dr. Ashley Pretorius. Dr. A. Pretorius is serving as the chairperson of the science faculty assessment committee as well as senate for the same committee he is also serving as Deputy Director at Mintek, NRF funding review panel member, MRC funding review panel member. Him and Dr. Marius they are working together on project for HIV/ADIS and Prostate cancer treatments.

Abstract

Abstract : SURVIVAL ANALYSIS AND CHARACTERIZATION OF ATP BINDING CASSETTE (ABC) DRUG TRANSPORTERS AND THIER ROLE IN BREAST CANCER CHEMOTHERAPY TREATMENT USING IN-SILICO APPROCH